Progressive multiple sclerosis
Information
- Disease name
- Progressive multiple sclerosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04749667 | Active, not recruiting | Phase 1/Phase 2 | Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis | August 9, 2021 | January 4, 2025 |
| NCT01305837 | Completed | Phase 2 | Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis | April 2011 | July 2013 |
| NCT01719159 | Completed | Phase 2 | Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis | November 2009 | June 2016 |
| NCT02282826 | Completed | Phase 1 | A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis | October 2014 | March 2016 |
| NCT02313285 | Completed | A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 | January 12, 2015 | April 20, 2022 | |
| NCT02559765 | Completed | Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK. | August 2015 | November 2015 | |
| NCT04120675 | Completed | N/A | Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis | November 9, 2018 | June 6, 2021 |
| NCT03980145 | Completed | N/A | G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis | May 2, 2017 | March 1, 2020 |
| NCT04201470 | Completed | N/A | Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis | December 9, 2019 | May 23, 2022 |
| NCT02583594 | Completed | Phase 1 | A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis | December 6, 2015 | March 1, 2021 |
| NCT02804594 | Completed | Phase 2 | A Study of Oxidative Pathways in MS Fatigue | October 1, 2016 | June 1, 2018 |
| NCT02977533 | Completed | Phase 1 | A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis | December 1, 2016 | May 16, 2018 |
| NCT03269071 | Completed | Phase 1 | Neural Stem Cell Transplantation in Multiple Sclerosis Patients | May 17, 2017 | July 31, 2021 |
| NCT03302806 | Completed | Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis | June 29, 2016 | October 24, 2018 | |
| NCT03423121 | Completed | Phase 1/Phase 2 | A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis | June 19, 2018 | July 5, 2022 |
| NCT03493841 | Completed | Phase 1 | Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis | June 8, 2018 | January 25, 2019 |
| NCT05706220 | Enrolling by invitation | Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis | June 13, 2022 | December 31, 2023 | |
| NCT05811013 | Not yet recruiting | N/A | Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis | March 27, 2024 | April 3, 2026 |
| NCT06451159 | Recruiting | Phase 1 | A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis | June 2024 | June 2027 |
| NCT05441488 | Recruiting | Phase 3 | Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis | June 28, 2022 | December 2025 |
| NCT05685784 | Recruiting | N/A | Multiple Sclerosis Prediction and Monitoring of Progression Study | March 1, 2022 | September 30, 2024 |
| NCT05740722 | Recruiting | Phase 2 | Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis | May 3, 2023 | December 30, 2027 |
| NCT05937802 | Recruiting | N/A | Osmotin Plant Protein for Progressive Multiple Sclerosis | January 2, 2023 | January 2, 2025 |
| NCT06261528 | Recruiting | Phase 1 | Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis | April 18, 2024 | December 1, 2025 |
| NCT04695080 | Recruiting | Phase 2/Phase 3 | ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis | June 25, 2021 | December 31, 2027 |
| NCT04856384 | Recruiting | N/A | Effect of Variance on Error Correction During Coupling | February 1, 2021 | December 31, 2024 |
| NCT02580669 | Terminated | N/A | Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis | June 16, 2014 | February 13, 2017 |
| NCT04289909 | Unknown status | N/A | Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) | March 2020 | October 2022 |
| NCT01815632 | Unknown status | Phase 2 | Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) | January 2014 | October 2019 |
| NCT03552211 | Unknown status | Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis | May 30, 2018 | April 30, 2019 | |
| NCT01364246 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica | January 2010 | December 2014 |